“clinical-trials” Archives

in
Entry Author Date Location
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
Radius Nabs FDA OK For New Bone Drug With Rival Amgen Close Behind 04/28/17 Boston
After Sarepta’s Surprising FDA Nod, CEO Kaye Plans to Resign 04/28/17 Boston
FDA Approves BioMarin Drug, A First for Rare Genetic Batten Disease 04/27/17 San Francisco
Gottlieb’s FDA Nomination Gets Committee Nod, Advances to Senate 04/27/17 National
Will New Data Open “Bottlenecks” For Biogen’s Pricey Spine Drug? 04/26/17 Boston
The Medicines Co., Alnylam Take Plunge, Outline Big Test For Heart Drug 04/26/17 New York
Forge Therapeutics Raises $15M to Take on Drug-Resistant Superbugs 04/25/17 San Diego
OncoMed Slashes Workforce After Two Clinical Trial Failures in Cancer 04/24/17 San Francisco
UniQure to Yank Pioneering Gene Therapy From Market in Europe 04/20/17 Boston
“Our Son’s Fate”: Parents Fighting for Kids’ Spine Drug Eye New Data 04/20/17 Boston
Want to Communicate Your Science? First, Step Back 04/19/17 San Francisco
Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street 04/17/17 Raleigh Durham
FDA Nixes Lilly, Incyte RA Drug, Seeks More Dosing and Safety Data 04/14/17 Indiana
TX Roundup: RetailMeNot, Gaurav Khandelwal, Zilliant, Xbiotech & More 04/13/17 Texas
Tocagen IPO Raises $85M to Test Gene Therapy in Brain Cancer Trials 04/13/17 San Diego
Lyndra’s Long-Acting Drug Delivery Technology Lands $23M Investment 04/13/17 Boston
FluGen Raises $2M More, Provides Update on Phase 1 Trial 04/11/17 Wisconsin
Emulate’s “Organ-on-a-Chip” Tech Picked for FDA Research Partnership 04/11/17 Boston
OncoMed Shares Sink as One Drug Fails, Bayer Kicks Back Two Others 04/10/17 San Francisco
FDA OKs 23andMe’s Direct-to-Consumer Genetic Tests, With Caution 04/06/17 San Francisco
Zavante Plans FDA Filing After Antibiotic Hits Clinical Trial Goals 04/06/17 San Diego
With Fresh Pneumonia Data, Paratek To Seek 2018 Antibiotic Approval 04/03/17 Boston
Cydan, NEA’s Orphan Drug Experiment, Pays Off in $200M Vtesse Deal 04/03/17 Boston
New Blood: Biotech CEOs Bring Fresh Experience to Houston Ecosystem 04/03/17 Texas
To Infinity and Beyond: Julian Adams on Missteps and His New Job 04/03/17 Boston
Boston Scientific to Acquire Heart Device Maker Symetis for $435M 03/30/17 Boston
Third Rock’s Tango Aims For Drugs That Turn Cancer Against Itself 03/30/17 Boston
Next Stop on Father’s Duchenne Quest: Wall Street? Solid Raises $50M 03/30/17 Boston
With FDA Approval, Genentech Drug Becomes First For Severe MS Cases 03/29/17 San Francisco
Page 1 of 23 next page »